Daily SPAC Update – August 20, 2024

by | Aug 20, 2024

ATMV Alphavest + AMC Corporation in $175M AI-Vision Deal. NOVV, MNTN Set Vote Dates. GTAC + Tyfon Culture Deal Terminated. CVII + CorpAcq Deal Terminated. YOTA Extension Vote Today.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEALS ANNOUNCED
Aug 19 | ATMV – Alphavest Acquisition Corp * + AMC Corporation

SPAC DEAL & EXTENSION VOTES SET
NOVV – Nova Vision Acquisition Corp * DEAL VOTE SET: Sep 10, 2024 * trust $12.23
MNTN – Everest Consolidator Acquisition Corp * EXTENSION VOTE SET: Aug 28, 2024 * trust $11.52

EXTENSION VOTES
YOTA – YOTTA ACQUISITION CORP * extend from August 22, 2024 to October 22, 2025

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-08-18: GTAC + Tyfon Culture Holdings Limited
2024-08-18: CVII + CorpAcq
2024-08-15: ADRT + GIGA TRONICS INC

YESTERDAY’S TOP SPAC GAINERS
4.91% ~ $ 12.60 | NPAB – New Providence Acquisition Corp. II (Pre-Deal)
4.39% ~ $ 10.47 | IFIN – InFinT Acquisition Corporation (Announced)
1.55% ~ $ 11.16 | OAKU – Oak Woods Acquisition Corp (Announced)

YESTERDAY’S TOP SPAC LOSERS
-12.28% ~ $ 12.50 | PTWO – Pono Capital Two, Inc. (Announced)
-4.58% ~ $ 11.66 | QOMO – Qomolangma Acquisition Corp. (Pre-Deal)
-3.00% ~ $ 11.45 | BYNO – byNordic Acquisition Corporation (Pre-Deal)
-2.65% ~ $ 12.30 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)
-1.69% ~ $ 11.60 | NVAC – NorthView Acquisition Corp (Announced)

LATEST SPAC IPO PERFORMANCE
Aug 16 | $ 10.00 | HOND – HCM II Acquisition Corp.
Aug 16 | $ 10.00 | SBXD – SilverBox Corp IV
Aug 09 | $ 9.98 | VACH – Voyager Acquisition Corp
Aug 06 | $ 9.95 | EQV – EQV Ventures Acquisition Corp.
Aug 01 | $ 10.02 | MBAV – M3-Brigade Acquisition V Corp.
Aug 01 | $ 10.00 | AAM – AA Mission Acquisition Corp.
Jul 24 | $ 10.07 | DTSQ – DT Cloud Star Acquisition Corp

Recent Analysis

Daily SPAC Update – May 1, 2025

Two SPAC IPOs to Start May — Republic Digital Upsized to $264M and Copley at $150M. ClimateRock Extension Vote. Aimfinity Delisting. Distoken Deal Vote Postponed.

Daily SPAC Update – April 30, 2025

AltEnergy Extends to May 2026. ClimateRock, Healthcare AI, Clean Energy Special Situations Extension Votes. Distoken and Chenghe Postpone Deal Votes.

Daily SPAC Update – April 29, 2025

Black Hawk Deal with Vesicor Therapeutics. Integrated Rail & Resources and Rigel Resource Set Extension Votes. Healthcare AI Acquisition Adjourns Vote to April 30.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.